Last reviewed · How we verify

NCT04495543

Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living'

Completed NA Last updated 9 November 2023
What this trial tests

NA trial testing Brief Skills for Safer Living in Suicidal Ideation in 77 participants. Completed in 24 March 2023.

Timeline
1 December 2020
Primary endpoint
24 March 2023
24 March 2023

Quick facts

Lead sponsorUnity Health Toronto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment77
Start date1 December 2020
Primary completion24 March 2023
Estimated completion24 March 2023
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Unity Health Toronto — full company profile →

Who can join

18 and older, any sex, with Suicidal Ideation or Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mental health concerns have been on the rise since the onset of the COVID-19 pandemic. The pandemic has worsened risk factors for suicide, including job loss, anxiety, depression, and loneliness. Timely and easy access to mental health services is a dire need, and this study will test the efficacy and feasibility of a brief clinical intervention, Brief Skills for Safer Living (Brief-SfSL), at reducing suicide risk. The goal of this study is to investigate whether Brief-SfSL, delivered online, is a suitable, acceptable and effective method for reducing suicide risk and providing timely mental health services. The results from this study will provide vital insight into effective interventions for suicide risk that are accessible and can be widely distributed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Suicidal Ideation

Currently open trials in the same condition.

Other Unity Health Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04495543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing